APO RESEARCH · REPORT
Pharmaceutical & Biotechnology Environmental Monitoring
Environmental monitoring during pharmaceutical and biopharmaceutical production is crucial for ensuring the safety of formulated drug products. While requirements for the control of both viable (living microorganisms) and non-viable particles (e.g. dust, hair, etc.) and other contaminants (i.e. trace metals, volatiles, etc.) for aseptic manufacturing operations are more extensive than those for non-sterile processes, the quantity of samples that must be analyzed and the amount of data generated can be daunting regardless of the final drug form, particularly for global companies with multiple production facilities.
Product & engineering
Understand the product.
Environmental monitoring during pharmaceutical and biopharmaceutical production is crucial for ensuring the safety of formulated drug products. While requirements for the control of both viable (living microorganisms) and non-viable particles (e.g. dust, hair, etc.) and other contaminants (i.e. trace metals, volatiles, etc.) for aseptic manufacturing operations are more extensive than those for non-sterile processes, the quantity of samples that must be analyzed and the amount of data generated can be daunting regardless of the final drug form, particularly for global companies with multiple production facilities.
This report studies the Pharmaceutical & Biotechnology Environmental Monitoring market. It covered Monitoring Equipment, Media, Reagents & Kits, Microbiology Services, Environmental Monitoring and Software used in Pharmaceutical & Biotechnology Environmental Monitoring.
Selected research
Industry Research
Pharmaceutical & Biotechnology Environmental Monitoring Industry Research Report 2026
Market perspective
Environmental monitoring during pharmaceutical and biopharmaceutical production is crucial for ensuring the safety of formulated drug products. While requirements for the control of both viable (living microorganisms) and non-viable particles (e.g. dust, hair, etc.) and other contaminants (i.e. trace metals, volatiles, etc.) for aseptic manufacturing operations are more extensive than those for non-sterile processes, the quantity of samples that must be analyzed and the amount of data generated can be daunting regardless of the final drug form, particularly for global companies with multiple production facilities.
This report studies the Pharmaceutical & Biotechnology Environmental Monitoring market. It covered Monitoring Equipment, Media, Reagents & Kits, Microbiology Services, Environmental Monitoring and Software used in Pharmaceutical & Biotechnology Environmental Monitoring.
Danaher Corporation, Thermo Fisher Scientific, Merck KGAA, Eurofins Sinensis and Lonza are the leading productors of Pharmaceutical & Biotechnology Environmental Monitoring. The top three accounted for about 20% of the total market.
Read the full market overview
North America is the largest market, accounting for about 40%. Europe is next with about 25%.
Report Scope
This report quantifies the global Pharmaceutical & Biotechnology Environmental Monitoring market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Pharmaceutical & Biotechnology Environmental Monitoring.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Pharmaceutical & Biotechnology Environmental Monitoring Market by Company
Danaher Corporation
Thermo Fisher Scientific
Merck KGaA
Eurofins Sinensis
Lonza
Biomerieux
VAI
Cosasco
RMONI
Amphenol Advanced Sensors
Vaisala
Pharmaceutical & Biotechnology Environmental Monitoring Segment by Type
Monitoring Equipment
Media
Software
Microbiology Services
Pharmaceutical & Biotechnology Environmental Monitoring Segment by Application
Pharmaceutical Industry
Biotechnology Industry
Academic & Research Institutes
Pharmaceutical & Biotechnology Environmental Monitoring Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical & Biotechnology Environmental Monitoring market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical & Biotechnology Environmental Monitoring and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical & Biotechnology Environmental Monitoring.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Pharmaceutical & Biotechnology Environmental Monitoring companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Monitoring Equipment
- Media
- Software
- Microbiology Services
Applications
- Pharmaceutical Industry
- Biotechnology Industry
- Academic & Research Institutes
Companies covered
- Danaher Corporation
- Thermo Fisher Scientific
- Merck KGaA
- Eurofins Sinensis
- Lonza
- Biomerieux
- VAI
- Cosasco
- RMONI
- Amphenol Advanced Sensors
- Vaisala
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Pharmaceutical & Biotechnology Environmental Monitoring by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Monitoring Equipment
- 2.2.3 Media
- 2.2.4 Software
- 2.2.5 Microbiology Services
- 2.3 Pharmaceutical & Biotechnology Environmental Monitoring by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Pharmaceutical Industry
- 2.3.3 Biotechnology Industry
- 2.3.4 Academic & Research Institutes
- 2.4 Assumptions and Limitations
3 Pharmaceutical & Biotechnology Environmental Monitoring Breakdown Data by Type
- 3.1 Global Pharmaceutical & Biotechnology Environmental Monitoring Historic Market Size by Type (2021-2026)
- 3.2 Global Pharmaceutical & Biotechnology Environmental Monitoring Forecasted Market Size by Type (2027-2032)
4 Pharmaceutical & Biotechnology Environmental Monitoring Breakdown Data by Application
- 4.1 Global Pharmaceutical & Biotechnology Environmental Monitoring Historic Market Size by Application (2021-2026)
- 4.2 Global Pharmaceutical & Biotechnology Environmental Monitoring Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Pharmaceutical & Biotechnology Environmental Monitoring Market Perspective (2021-2032)
- 5.2 Global Pharmaceutical & Biotechnology Environmental Monitoring Growth Trends by Region
- 5.2.1 Global Pharmaceutical & Biotechnology Environmental Monitoring Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Pharmaceutical & Biotechnology Environmental Monitoring Historic Market Size by Region (2021-2026)
- 5.2.3 Pharmaceutical & Biotechnology Environmental Monitoring Forecasted Market Size by Region (2027-2032)
- 5.3 Pharmaceutical & Biotechnology Environmental Monitoring Market Dynamics
- 5.3.1 Pharmaceutical & Biotechnology Environmental Monitoring Industry Trends
- 5.3.2 Pharmaceutical & Biotechnology Environmental Monitoring Market Drivers
- 5.3.3 Pharmaceutical & Biotechnology Environmental Monitoring Market Challenges
- 5.3.4 Pharmaceutical & Biotechnology Environmental Monitoring Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Pharmaceutical & Biotechnology Environmental Monitoring Players by Revenue
- 6.1.1 Global Top Pharmaceutical & Biotechnology Environmental Monitoring Players by Revenue (2021-2026)
- 6.1.2 Global Pharmaceutical & Biotechnology Environmental Monitoring Revenue Market Share by Players (2021-2026)
- 6.2 Global Pharmaceutical & Biotechnology Environmental Monitoring Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Pharmaceutical & Biotechnology Environmental Monitoring Head Office and Area Served
- 6.4 Global Pharmaceutical & Biotechnology Environmental Monitoring Players, Product Type & Application
- 6.5 Global Pharmaceutical & Biotechnology Environmental Monitoring Manufacturers Established Date
- 6.6 Global Pharmaceutical & Biotechnology Environmental Monitoring Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Pharmaceutical & Biotechnology Environmental Monitoring Market Size (2021-2032)
- 7.2 North America Pharmaceutical & Biotechnology Environmental Monitoring Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Pharmaceutical & Biotechnology Environmental Monitoring Market Size by Country (2021-2026)
- 7.4 North America Pharmaceutical & Biotechnology Environmental Monitoring Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Pharmaceutical & Biotechnology Environmental Monitoring Market Size (2021-2032)
- 8.2 Europe Pharmaceutical & Biotechnology Environmental Monitoring Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Pharmaceutical & Biotechnology Environmental Monitoring Market Size by Country (2021-2026)
- 8.4 Europe Pharmaceutical & Biotechnology Environmental Monitoring Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Pharmaceutical & Biotechnology Environmental Monitoring Market Size (2021-2032)
- 9.2 Asia-Pacific Pharmaceutical & Biotechnology Environmental Monitoring Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Pharmaceutical & Biotechnology Environmental Monitoring Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Pharmaceutical & Biotechnology Environmental Monitoring Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Pharmaceutical & Biotechnology Environmental Monitoring Market Size (2021-2032)
- 10.2 South America Pharmaceutical & Biotechnology Environmental Monitoring Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Pharmaceutical & Biotechnology Environmental Monitoring Market Size by Country (2021-2026)
- 10.4 South America Pharmaceutical & Biotechnology Environmental Monitoring Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Pharmaceutical & Biotechnology Environmental Monitoring Market Size (2021-2032)
- 11.2 Middle East & Africa Pharmaceutical & Biotechnology Environmental Monitoring Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Pharmaceutical & Biotechnology Environmental Monitoring Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Pharmaceutical & Biotechnology Environmental Monitoring Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Danaher Corporation
- 12.1.1 Danaher Corporation Company Information
- 12.1.2 Danaher Corporation Business Overview
- 12.1.3 Danaher Corporation Revenue in Pharmaceutical & Biotechnology Environmental Monitoring Business (2021-2026)
- 12.1.4 Danaher Corporation Pharmaceutical & Biotechnology Environmental Monitoring Product Portfolio
- 12.1.5 Danaher Corporation Recent Developments
- 12.2 Thermo Fisher Scientific
- 12.2.1 Thermo Fisher Scientific Company Information
- 12.2.2 Thermo Fisher Scientific Business Overview
- 12.2.3 Thermo Fisher Scientific Revenue in Pharmaceutical & Biotechnology Environmental Monitoring Business (2021-2026)
- 12.2.4 Thermo Fisher Scientific Pharmaceutical & Biotechnology Environmental Monitoring Product Portfolio
- 12.2.5 Thermo Fisher Scientific Recent Developments
- 12.3 Merck KGaA
- 12.3.1 Merck KGaA Company Information
- 12.3.2 Merck KGaA Business Overview
- 12.3.3 Merck KGaA Revenue in Pharmaceutical & Biotechnology Environmental Monitoring Business (2021-2026)
- 12.3.4 Merck KGaA Pharmaceutical & Biotechnology Environmental Monitoring Product Portfolio
- 12.3.5 Merck KGaA Recent Developments
- 12.4 Eurofins Sinensis
- 12.4.1 Eurofins Sinensis Company Information
- 12.4.2 Eurofins Sinensis Business Overview
- 12.4.3 Eurofins Sinensis Revenue in Pharmaceutical & Biotechnology Environmental Monitoring Business (2021-2026)
- 12.4.4 Eurofins Sinensis Pharmaceutical & Biotechnology Environmental Monitoring Product Portfolio
- 12.4.5 Eurofins Sinensis Recent Developments
- 12.5 Lonza
- 12.5.1 Lonza Company Information
- 12.5.2 Lonza Business Overview
- 12.5.3 Lonza Revenue in Pharmaceutical & Biotechnology Environmental Monitoring Business (2021-2026)
- 12.5.4 Lonza Pharmaceutical & Biotechnology Environmental Monitoring Product Portfolio
- 12.5.5 Lonza Recent Developments
- 12.6 Biomerieux
- 12.6.1 Biomerieux Company Information
- 12.6.2 Biomerieux Business Overview
- 12.6.3 Biomerieux Revenue in Pharmaceutical & Biotechnology Environmental Monitoring Business (2021-2026)
- 12.6.4 Biomerieux Pharmaceutical & Biotechnology Environmental Monitoring Product Portfolio
- 12.6.5 Biomerieux Recent Developments
- 12.7 VAI
- 12.7.1 VAI Company Information
- 12.7.2 VAI Business Overview
- 12.7.3 VAI Revenue in Pharmaceutical & Biotechnology Environmental Monitoring Business (2021-2026)
- 12.7.4 VAI Pharmaceutical & Biotechnology Environmental Monitoring Product Portfolio
- 12.7.5 VAI Recent Developments
- 12.8 Cosasco
- 12.8.1 Cosasco Company Information
- 12.8.2 Cosasco Business Overview
- 12.8.3 Cosasco Revenue in Pharmaceutical & Biotechnology Environmental Monitoring Business (2021-2026)
- 12.8.4 Cosasco Pharmaceutical & Biotechnology Environmental Monitoring Product Portfolio
- 12.8.5 Cosasco Recent Developments
- 12.9 RMONI
- 12.9.1 RMONI Company Information
- 12.9.2 RMONI Business Overview
- 12.9.3 RMONI Revenue in Pharmaceutical & Biotechnology Environmental Monitoring Business (2021-2026)
- 12.9.4 RMONI Pharmaceutical & Biotechnology Environmental Monitoring Product Portfolio
- 12.9.5 RMONI Recent Developments
- 12.10 Amphenol Advanced Sensors
- 12.10.1 Amphenol Advanced Sensors Company Information
- 12.10.2 Amphenol Advanced Sensors Business Overview
- 12.10.3 Amphenol Advanced Sensors Revenue in Pharmaceutical & Biotechnology Environmental Monitoring Business (2021-2026)
- 12.10.4 Amphenol Advanced Sensors Pharmaceutical & Biotechnology Environmental Monitoring Product Portfolio
- 12.10.5 Amphenol Advanced Sensors Recent Developments
- 12.11 Vaisala
- 12.11.1 Vaisala Company Information
- 12.11.2 Vaisala Business Overview
- 12.11.3 Vaisala Revenue in Pharmaceutical & Biotechnology Environmental Monitoring Business (2021-2026)
- 12.11.4 Vaisala Pharmaceutical & Biotechnology Environmental Monitoring Product Portfolio
- 12.11.5 Vaisala Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst